Covid-19 Vaccine Hesitancy Among Health Care Workers in Thailand

The Comparative Results of Two Cross-Sectional Online Surveys Before and After Vaccine Availability

Bibliographic Data

ID22076508
AuthorsChatkamol Pheerapanyawaranun (0000-0002-5050-5571, Ministry of Public Health), Yi Wang (0000-0003-2228-7009, National University of Singapore), Nachawish Kittibovorndit (Ministry of Public Health), Nopphadol Pimsarn (0000-0002-6037-0412, Ministry of Public Health), Kanchanok Sirison (0000-0001-6591-336X, Ministry of Public Health), Yot Teerawattananon (0000-0003-2217-2930, Ministry of Public Health), Wanrudee Isaranuwatchai (0000-0002-8368-6065, Ministry of Public Health, corresponding author)
Year2022
Volume10
Pages834545-834545
Publication date2022-08-01
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.834545
PMID35979452
OpenAlexW4289130301
LanguageEN
Citations received1
References cited24

Introduction: The arrival of COVID-19 vaccines in Thailand has supported the fight against the COVID-19 pandemic. This study examined COVID-19 vaccine acceptance among health care workers (HCWs) in Thailand before and after vaccines' availability and investigated factors (both enablers and barriers) affecting their decisions. Methods: Two online self-administered questionnaires were distributed to HCWs in two time-periods: (1) the pre-vaccine arrival period (prior to COVID-19 vaccines' arrival in Thailand, January 28 to February 16, 2021); and (2) the post-vaccine arrival period (April 21 to May 9, 2021). Descriptive analyses and multinomial logistic regression were conducted to examine factors associated with vaccine hesitancy. Results: There were 55,068 respondents in the pre-vaccine arrival period and 27,319 respondents in the post-vaccine arrival period. In the pre-vaccine arrival period, 55.0% of respondents were willing to accept the vaccines, 35.4% were uncertain, and 9.6% declined. In the post-vaccine arrival period, ~16% already received two doses of either the Sinovac or AstraZeneca vaccine, and 43% were administered one dose. Approximately 12% of those who had received the first dose were uncertain or not willing to accept the second dose. Demographic and socio-demographic factors of participants, including their sex, place of residence, and whether they were frontline COVID-19 workers, were found to be the significant factors explaining vaccination hesitancy. Moreover, when comparing the pre-vaccine arrival and post-vaccine arrival periods, it was found that older HCWs were more likely to decline a COVID-19 vaccine in the pre-vaccine arrival period; on the other hand, older HCWs were less likely to decline or be uncertain to receive a COVID-19 vaccine in the post-vaccine arrival period. Conclusion: Information on HCWs' acceptance of COVID-19 vaccines, including who is more likely to accept the vaccines, could assist in planning vaccine allocation to both HCWs and the general public, who often believe HCWs' recommendations. This study's findings set out how policies can be addressed to reduce vaccine hesitancy. This study also highlights HCWs' characteristics (including gender, work region, occupation, and history of receiving influenza vaccination) and the reasons they cited for their vaccine acceptance or hesitance

Arrival time · Cross-sectional study · Disease · Environmental health · Family medicine · Logistic regression · Multinomial logistic regression · Pandemic · Residence · Vaccination · COVID-19 Impact on Reproduction · Demography · Medicine · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Immunology · Internal Medicine

Tools

Open DOIOpen Access